Modulation of Ca2+ transients in cultured endothelial cells in response to fluid flow through alphav integrin

Life Sci. 2007 Oct 27;81(19-20):1421-30. doi: 10.1016/j.lfs.2007.08.041. Epub 2007 Sep 19.

Abstract

In order to determine whether integrin dynamics is associated with intracellular Ca(2+) concentration ([Ca(2+)](i)) mobilization in ECs in response to hemodynamic forces, changes in [Ca(2+)](i) in fluo-4-loaded cultured bovine aortic endothelial cells (BAECs) under fluid flow conditions were visualized employing laser scanning confocal microscopy. Following the onset of flow stimulus, transient increases in [Ca(2+)](i) occurred several times in individual BAECs during the 30-min observation period. The frequency of these [Ca(2+)](i) transients was clearly reduced by the application of an integrin antagonist (GRGDSP peptide). Furthermore, treatment of cells with an integrin activator (Mn(2+)) resulted in reduction of peak [Ca(2+)](i) levels and elevated frequency, which was markedly rescued upon GRGDSP administration. In contrast, an actin de-polymerizing agent (cytochalasin D) exerted no inhibitory effects; rather, cytochalasin D more likely facilitated [Ca(2+)](i) transients. Moreover, [Ca(2+)](i) transients, which were suppressed by short interference RNA-induced silencing of alphav integrin, exhibited greater frequently in cells cultured on vitronectin substratum in comparison with those cultured on fibronectin or collagen substratum. Either removal of extracellular Ca(2+), application of an inhibitor of endoplasmic reticulum Ca(2+)-ATPase (thapsigargin) or non-selective cation channel blocker (La(3+)) inhibited the [Ca(2+)](i) transients. Additionally, [Ca(2+)](i) transients were attenuated by extracellular signal-regulated kinase (ERK) kinase inhibitor (U0126); in contrast, [Ca(2+)](i) transients were unaffected by tyrosine kinase inhibitor (genistein) or phosphatidylinositol 3-kinase (PI3K) inhibitor (LY294002). Therefore, our findings revealed that alphav integrin dynamics modulates the frequency of flow-induced [Ca(2+)](i) transients in BAECs in an ERK-dependent fashion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Butadienes / pharmacology
  • Calcium / metabolism*
  • Calcium / pharmacology
  • Cattle
  • Cell Adhesion / drug effects
  • Cells, Cultured
  • Collagen Type IV / pharmacology
  • Cytoskeleton / drug effects
  • Cytoskeleton / metabolism
  • Cytoskeleton / physiology
  • Dose-Response Relationship, Drug
  • Endothelial Cells / cytology
  • Endothelial Cells / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Fibronectins / pharmacology
  • Integrin alphaV / drug effects
  • Integrin alphaV / genetics
  • Integrin alphaV / metabolism*
  • Manganese / pharmacology
  • Microscopy, Confocal
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Models, Biological
  • Nitriles / pharmacology
  • Oligopeptides / pharmacology
  • RNA Interference
  • Rheology / methods
  • Stress, Mechanical
  • Vitronectin / pharmacology

Substances

  • Actins
  • Butadienes
  • Collagen Type IV
  • Enzyme Inhibitors
  • Fibronectins
  • Integrin alphaV
  • Nitriles
  • Oligopeptides
  • U 0126
  • Vitronectin
  • Manganese
  • glycyl-arginyl-glycyl-aspartyl-seryl-proline
  • Extracellular Signal-Regulated MAP Kinases
  • Mitogen-Activated Protein Kinase Kinases
  • Calcium